Abstract
Antineoplastic drugs are a wide and heterogeneous group of substances that, as universally known, can cause highly severe toxic effects to whoever is exposed. From an occupational safety point of view, surface contaminations inside preparation and administration units are a growing issue and therefore require the development and implementation of sensible and fast monitoring methods. The unlikelihood of a unique all-embracing chromatography, able to correctly retain and separate each analyte led to the need to create an orthogonal normal phase analysis, which might be able to fill the gaps in the more common reversed-phase ones. An existing hydrophilic interaction method has thus been expanded to 6 other drugs and applied to real samples after an evaluation of its performances. The experimental data were then used to evaluate the possibility of estimating reliable relationships between the chromatographic retention and the chemical-structural features of the drugs under analysis.
Subject
Filtration and Separation,Analytical Chemistry
Reference44 articles.
1. Global Anticancer Drugs Market to Record 6.7% CAGR through 2027https://www.biospace.com/article/global-anticancer-drugs-market-to-record-6-7-percent-cagr-through-2027/
2. Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature
3. Chromosomal aberrations, sister chromatid exchanges, and micronuclei in lymphocytes of oncology department personnel handling anti-neoplastic drugs
4. Occupational exposure to cytostatic/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: A systematic review of the literature and meta-analysis
5. Directive 2004/37/EC of the European Parliament and of the Council of 29 April 2004 on the Protection of Workers from the Risks Related to Exposure to Carcinogens or Muta-Gens at Work (Sixth Individual Directive within the Meaning of Article 16(1) of Council Directive 89/391/EEC)https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:229:0023:0034:EN:PDF
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献